Cargando…
SAT-645 An Indication for Continuous Glucose Monitoring in Glucocorticoid-Treated Patients with Diabetes Mellitus
Introduction: Continuous glucose monitoring systems (CGMS) are increasingly used to optimize management of diabetes mellitus (DM) in the outpatient setting. CGMS measure interstitial glucose concentration, which closely approximates plasma glucose after a short time lag, every 5 min for up to 72 h....
Autores principales: | Sandhu, Harjyot, Gilden, Janice L, Wentz, Lynne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209461/ http://dx.doi.org/10.1210/jendso/bvaa046.967 |
Ejemplares similares
-
MON-145 An Unusual Cause of Hypoglycemia in a Non-Diabetic Elderly Male
por: Sandhu, Harjyot, et al.
Publicado: (2019) -
SAT104 Evaluation Of Glucose Variability By Continuous Glucose Monitoring In Patients With Diabetes Mellitus And History Of Stroke
por: Musurakis, Clio, et al.
Publicado: (2023) -
SAT-640 Glycemic Profile of Intravenous Glucocorticoid Induced Hyperglycemia Using Continuous Glucose Monitoring
por: Zhang, Fan, et al.
Publicado: (2020) -
MON-134 Use of CGMS for Evaluating Hypoglycemia in Non-Diabetic Patients
por: Shrestha, Isha, et al.
Publicado: (2019) -
SAT-127 Hypoglycemic Episodes in Type 2 Diabetes Mellitus : Continuous Glucose Monitoring Versus Self Monitoring of Blood Glucose
por: Aung, Tin, et al.
Publicado: (2019)